La Gro's practice has vast experience in assisting with the corporate restructuring of healthcare entities and UPC infringement proceedings. Practice head Marleen van den Horst is well known for handling SPC and regulatory issues, and often acts for large pharmaceutical companies in matters concerning clinical trials and orphan medicinal products. Benjamin Niemeijer has expertise in IP litigation, and often assists healthcare providers with tech-related transfers.
Legal 500 redaktioneller Kommentar
- Profil
Referenzen
Unabhängig vom Legal 500-Forschungsteam zusammengestellt.
‘The team are very knowledgeable and great to work with. Very reliable.’
‘Pleasant personal attention, capable of providing timely suitable solutions.’
‘Benjamin Niemeijer is knowledgeable and truly cares for his clientele, and is able to provide the correct input needed to make good decisions and to make the process seamless.’
Kernmandanten
- Stichting Alrijne Zorggroep
- Insud Pharma
- Leiden University Medical Center
- Move the Brain
- Oldelft Ultrasound
- Stada Arzneimittel
- Adalvo
- Focus Care Pharmaceuticals
- Amgen
- OrthoApnea
Highlight-Mandate
- Represented Amgen in biosimilar patent litigation.
- Represented Insud Pharma in invalidity proceedings concerning pharmaceutical patents.
- Representing OrthoApnea and Vivisol B in patent infringement proceedings.
Anwält*innen
Führende Partner*innen
Die stärksten Partner*innen ihres Praxisbereichs, die eine führende Rolle in signifikanten Mandaten einnehmen und weitreichende Anerkennung unter Wettbewerbern und Mandanten genießen.
Praxisleitung
Marleen van den Horst
Weitere Kernanwält*innen
Benjamin Niemeijer; Iris Arts